Can DMARDs reduce diabetes risk?
Source: JAMA Area: News A large retrospective cohort study involving patients with rheumatoid arthritis (RA) and psoriasis found that those treated with hydroxychloroquine or tumour necrosis factor (TNF) inhibitors had a lower risk of developing diabetes over follow-up compared to other disease-modifying antirheumatic drugs (DMARD). nbsp; Patients with systemic inflammatory conditions such as RA are at increased risk of diabetes, however there is evidence that drugs that modify the inflammatory response may reduce the risk. The authors of this study used North American healthcare administrative data to examine the relationship between DMARD medications and the risk of newly diagnosed diabetes in patients with RA or psoriasis. They constructed a cohort of patients with a diagnosis of ...

Hydroxychloroquine‐induced acute psychosis in a systemic lupus erythematosus female
Conclusion: Awareness of chloroquine‐induced psychosis is very important, and psychiatric intervention is needed as soon as possible after this occurs. (Source: Acta Neuropsychiatrica)